Japan Point-of-care Molecular Diagnostics Market Size & Outlook

The point-of-care molecular diagnostics market in Japan is expected to reach a projected revenue of US$ 456.0 million by 2030. A compound annual growth rate of 5.1% is expected of Japan point-of-care molecular diagnostics market from 2024 to 2030.
Revenue, 2023 (US$M)
$321.6
Forecast, 2030 (US$M)
$456.0
CAGR, 2024 - 2030
5.1%
Report Coverage
Japan

Japan point-of-care molecular diagnostics market, 2018-2030 (US$M)

Japan

Related Markets

Japan point-of-care molecular diagnostics market highlights

  • The Japan point-of-care molecular diagnostics market generated a revenue of USD 321.6 million in 2023 and is expected to reach USD 456.0 million by 2030.
  • The Japan market is expected to grow at a CAGR of 5.1% from 2024 to 2030.
  • In terms of segment, infectious diseases was the largest revenue generating application in 2023.
  • Oncology is the most lucrative application segment registering the fastest growth during the forecast period.


Point-of-care molecular diagnostics market data book summary

Market revenue in 2023USD 321.6 million
Market revenue in 2030USD 456.0 million
Growth rate5.1% (CAGR from 2023 to 2030)
Largest segmentInfectious diseases
Fastest growing segmentOncology
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases
Key market players worldwideRoche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis


Other key industry trends

  • In terms of revenue, Japan accounted for 6.2% of the global point-of-care molecular diagnostics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan point-of-care molecular diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 401.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Point-of-Care Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website

Japan point-of-care molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.


Infectious diseases was the largest segment with a revenue share of 93.53% in 2023. Horizon Databook has segmented the Japan point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.


In 2022, Japan held the second-largest revenue share of the market. The country is reported to have the largest geriatric population worldwide due to the increased life expectancy as a result of medical advancements and reduced fertility rates. This increase in geriatric population is expected to surge significantly over the coming years.

According to Japan’s Ministry of Internal Affairs and Communications, as of September 2021, about 36.4 million, or 29.1% of the country’s population, is aged 65 or above. It represents an increase of 220,000 people from 2020. Hence, the increasing geriatric population is expected to create lucrative opportunities for developing POC diagnostics and testing solutions.

Reasons to subscribe to Japan point-of-care molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan point-of-care molecular diagnostics market databook

  • Our clientele includes a mix of point-of-care molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Japan point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan point-of-care molecular diagnostics market size, by application, 2018-2030 (US$M)

Japan Point-of-Care Molecular Diagnostics Market Outlook Share, 2023 & 2030 (US$M)

Japan point-of-care molecular diagnostics market size, by application, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more